Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nuo Therapeutics (AURX)
OTHER OTC:AURX
Holding AURX?
Track your performance easily
AURX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.25 - $0.98
Previous Close$0.55
Volume6.00K
Average Volume (3M)29.41K
Market Cap
$25.01M
Enterprise Value$24.73M
Total Cash (Recent Filing)$473.04K
Total Debt (Recent Filing)$194.04K
Price to Earnings (P/E)―
Beta-1.05
Next Earnings
Aug 08, 2022EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding45,466,238
10 Day Avg. Volume3,256
30 Day Avg. Volume29,405
Standard Deviation1360.68
R-Squared0.00155
Alpha200.59
Financial Highlights & Ratios
Price to Book (P/B)55.00
Price to Sales (P/S)24.31
Price to Cash Flow (P/CF)-9.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue27.11
Enterprise Value/Gross Profit33.66
Enterprise Value/Ebitda-8.97
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nuo Therapeutics News
PremiumCompany Announcements
Nuo Therapeutics Announces Annual Report Filing Delay
Ownership Overview
76.11% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
23.89% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AURX FAQ
What was Nuo Therapeutics’s price range in the past 12 months?
Nuo Therapeutics lowest stock price was $0.25 and its highest was $0.98 in the past 12 months.
What is Nuo Therapeutics’s market cap?
Currently, no data Available
When is Nuo Therapeutics’s upcoming earnings report date?
Nuo Therapeutics’s upcoming earnings report date is Aug 08, 2022 which is 774 days ago.
How were Nuo Therapeutics’s earnings last quarter?
Currently, no data Available
Is Nuo Therapeutics overvalued?
According to Wall Street analysts Nuo Therapeutics’s price is currently Overvalued.
Does Nuo Therapeutics pay dividends?
Nuo Therapeutics does not currently pay dividends.
What is Nuo Therapeutics’s EPS estimate?
Nuo Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuo Therapeutics have?
Nuo Therapeutics has 45,466,236 shares outstanding.
What happened to Nuo Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nuo Therapeutics?
Currently, no hedge funds are holding shares in AURX
---
Nuo Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-23.07%
12-Months-Change
Fundamentals
Return on Equity
-503.61%
Trailing 12-Months
Asset Growth
2.54%
Trailing 12-Months
Company Description
Nuo Therapeutics
Nuo Therapeutics, Inc. engages in developing and marketing products for chronic wound care. It offers Aurix point of care technology for the safe and efficient separation of autologous blood to produce a platelet based therapy for the chronic wound care market. The company was founded on April 29, 1998 and is headquartered in Gaithersburg, MD.
---
Technical Analysis
Brainstorm Cell Therapeutics
―
Capricor Therapeutics
―
Cyclacel Pharmaceuticals
―
Genprex
―
---